Recent data on lobular neoplasia of the breast: The pathologist's opinion;Données récentes sur les néoplasies lobulaires du sein: Le point de vue du pathologiste

Bulletin du Cancer

Volumn 92, Issue 5, 2005, Pages 453-458

  Bibeau, Frédéric ^a   Borrelly, Cécile ^a   Chateau, Marie Christine ^a   Saingra, Bernard ^a   Lemanski, Claire ^a   Masson, Bruno ^a   Rouanet, Philippe ^a   Gutowski, Marian ^a  

^a CENTRE VAL D AURELLE   (France)

Author keywords

Lobular invasive carcinoma; Lobular neoplasia; Microcalcification; Non palpable breast lesion; Percutaneous guided biopsie; Pleomorphic lobular neoplasia

Indexed keywords

BREAST BIOPSY; BREAST CALCIFICATION; BREAST CANCER; BREAST HYPERPLASIA; BREAST LOBULAR NEOPLASIA; CARCINOMA IN SITU; HUMAN; MAMMOGRAPHY; PATHOLOGIST; PATIENT MONITORING; PROGNOSIS; REVIEW; TUMOR NECROSIS; WORLD HEALTH ORGANIZATION; BIOPSY; BREAST; BREAST TUMOR; CHEMISTRY; FEMALE; LUNG CARCINOMA; NOMENCLATURE; PATHOLOGY; PHENOTYPE; PREVALENCE;

CADHERIN;

BIOPSY; BREAST; BREAST NEOPLASMS; CADHERINS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; FEMALE; HUMANS; PHENOTYPE; PREVALENCE; TERMINOLOGY;

EID: 20344386509     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Tavassoli FA, Millis RR, Boeckert W, Lakhani SR. Lobular neoplasia. In: Tavassoli FA, Devilee P, eds. Tumors of the breast and female genital organs. World Health Organisation Classification of tumors. Lyon: IARC Press, 2003: 60-4.
2. Sigal-Zafrani B, Vincent-Salomon A, Sastre-Garau X. (Risk) indicator lesions and carcinoma in situ of the breast. Lobular hyperplasia/neoplasia. Histopathology 2002; 41 (suppl.2): 346-63.
3. Jacobs TW, Connolly JL, Schnitt SJ. Non malignant lesions in breast core needle biopsies. To excise or not to excise? Am J Surg Pathol 2002; 26: 1095-110.
4. Renshaw AA, Cattagena N, Derhagopian RP, Goud EW. Lobular neoplasia in breast core needle biopsy specimens is not associated with an increased risk of ductal carcinoma in situ or invasive carcinoma. Am J Clin Pathol 2002; 117: 797-9.
5. Middleton LP, Shakeitha G, Stephens T, Stelling CB, Sneige N, Sahin AA. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised? Modern Path 2003; 16: 120-9.
6. Fisher ER, Costantino JP, Fisher B, Palekar AS, Paik SM, Suarez CM, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-years observation concerning lobular carcinoma in situ. Cancer 1996; 78: 1403-16.
7. O'Driscoll D, Britton P, Bobtow L, Wishart G, Shinnacamby R, Warren R. Lobular carcinoma in situ on core biopsy. What is the clinical significance? Clin Radiol 2001; 56: 216-20.
8. Haagensen CD, Lane N, Lattes R, Bodian C. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 1978; 42: 737-69.
9. Rosen PP, Kosloff C, Lieberman PH, Adair F, Braun Jr DW. Lobular carcinoma in utu of the breast. Detailed analysis of 9 patients with average follow-up of 24 years. Am J Surg Pathol 1978; 2: 225-51.
10. Page DL, Kidd Jr TE, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more expensive disease. Hum Pathol 1991; 22: 1232-9.
11. Ottesen GL, Gaversen HP, Blichert-Toft M, Zedeler K, Andersen JA. Lobular carcinoma in situ of the female breast. Short term results of a prospective nation wide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 1993; 17: 14-21.
12. Page D, Schuyler PA, Dupont WD, Jensen RA, Plummet WD, Simpson JF. Atypical lobular neoplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 2003; 361: 125-9.
13. Reis-Filho JS, Lakhani SR. The diagnosis and management of pre-invasive breast disease: genetic alterations in pre-invasive lesions. Breast Cancer Res 2003; 5: 313-9.
14. Dauplat MM, Penault-Llorca F. Classification des lésions pré-invasives et des carcinomes in situ: doutes, controverses, proposition de nouvelles classifications. Bull Cancer 2004; 91: S205-S210.
15. Schnitt SJ, Morrow M. Lobular carcinoma in situ: current concepts and controversies. Semin Diagn Pathol 1999; 16: 209-23.
16. Sapino A, Frigerio A, Peterse JL, Arisio R, Coluccia C, Bussolari G. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch 2000; 436: 421-30.
17. Tavassoli F. Pathology of the breast. 2nd edition. Stanford, Connecticut: Appleton Lange, 1999.
18. Georgian-Smith D, Lawron TJ. Calcifications of lobular carcinoma of the breast: radiologic-pathologic correlation. Am J Roentgenol 2001; 176: 1255-9.
19. Crisi GM, Mandavilli S, Cronin E, Ricci A. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy. Am J Surg Pathol 2003; 27: 325-33.
20. De Leeuw W, Berx G, B.J VC, Peterse JL, Van de Vuver MJ, Lirinov S, et al. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. Am J Path 1997; 183: 404-11.
21. Vos CB, Cleton-Jansen AM, Berx G, De Leeuw WJ, Ter Haar NT, Van Roy F, et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 1997; 76: 1131-3.
22. Jacobs TW, Pliss N, Kouria G, Schnitt SJ. Carcinomas in situ of rhe breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 2001; 25: 229-36.
23. Acs G, Lawton TJ, Rebbeck TR, LiVolsi VA, Zhang PJ. Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. Am J Clin Pathol 2001; 25: 85-98.
24. Goldstein NS, Bassi D, Watts JC, Layfield LJ, Yaziji H, Gown AM. E-cadherin reactivity of 95 non invasive ductal and lobular lesions of the breast. Implications for the interpretation of problematic lesions. Am J Clin Pathol 2001; 115: 534-42.
25. Bratthauer GL, Moinfar F, Stamarakos MD, Mezzetti TP, Shekitka KM, Man YG, et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal and hybrid mammary intraepithelial neoplasias. Hum Pathol 2002; 33: 620-7.
26. Maluf HM, Swanson PE, Koerner FC. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol 2001; 25: 237-44.
27. Palacios J, Sarrio D, Garcia-Macia MC, Bryant B, Sobel ME, Merino MJ. Frequent E-cadherin gene inactivation by loss of heterozygoty in pleomorphic lobular carcinoma of the breast. Mod Path 2003; 16: 674-8.
28. Sneige N, Wang J, Baker BA, Krishnamurthy S, Middelton LP. Clinical, histopathological and biological features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Path 2002; 15: 1044-50.
29. Bratthauer GL, Tavassoli FA. Lobular intraepithelial neoplasia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch 2002; 440: 134-8.
30. Shin JS, Rosen PP. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Lab Pathol Med 2002; 126: 697-701.
31. Liberman L, Sama M, Susnik B, Rosen PP, La Trenta LR, Morris EA, et al. Lobular carcinoma in situ at percutaneous breast biopsy: surgical findings. Am J Roentgenol 1999; 173: 291-9.
32. Bibeau F, Chateau MC, Masson M. Prise en charge des lésions mammaires infra-cliniques par macrobiopsies assistées pat le vide (procédure mammotome®). Expérience du centre Val d'Aurelle à propos d'une série de 560 procédures. Ann Pathol 2003; 23: 582-92.
33. Maluf HM. Differential diagnosis of solid carcinoma in situ. Semin Diagn Pathol 2004; 21: 25-31.
34. Lerwill MF. Current practical applications of diagnostic immunohistochemistry in breast pathology. Am J Surg Pathol 2004; 28: 1076-91.
35. Molimard J. Des masropathies à risque aux carcinomes canalaires in situ. Reproductibilité de l'identification et de la classification des lésions. Que faut-il mettre dans le compte rendu? Standards et recommandations. Le sein 2000; 10: 36-43.
36. Sigal-Zafrani B, Vincent-Salomon A, Meunier M, El Khoury C, Thibault F, Sastre-Garau X. Place du pathologiste dans les nouvelles strarégies thérapeuriques. L'expérience de la pathologie mammaire. Analyse des micro/macrobiopsies de lésions mammaires infra-cliniques. Est-elle représentative des lésions? Comment formuler les comptes rendus? Ann Pathol 2002; 22(suppl. 1): S48-S49.
37. Sigal-Zafrani B, Vincent-Salomon A, Penault-Llorca F, Sastre-Garau X. Néoplasies lobulaires. Ann Pathol 2003; 23: 547-53.
38. Hoda SA, Harigopal M. Expert opinion. Reporting needle core biopsies of breast in situ carcinomas. Histopathology 2003; 43: 84-90.
39. Anonymous. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. NHS Cancer screening programmes. 2001; 50.
40. Anaes. Conduite à renir diagnostique devant une image mammographique infraclinique anormale. Recommandations pour la pratique clinique. Le cancer du sein 1998: 145-79 (http://www.anaes.fr).
41. Bibeau F. À propos de l'examen histologique extemporané des lésions mammaires infracliniques. Bull Cancer 2004; 91: 205-6.